Clinical Trials Related to Brexucabtagene Autoleucel

Related studies linked through entity extraction aliases.

Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL

Status: RECRUITING
Phase: PHASE2

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

Status: AVAILABLE
Phase: N/A

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies

Status: TERMINATED
Phase: PHASE2

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Status: ENROLLING_BY_INVITATION
Phase: N/A

Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

Status: COMPLETED
Phase: PHASE2

Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Status: TERMINATED
Phase: PHASE1

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Status: COMPLETED
Phase: PHASE1/PHASE2

Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2)

Status: COMPLETED
Phase: PHASE2